Unichem Laboratories Ltd's Q3FY25 Quarter Results
- 07 Feb 2025
Result Summary
- Unichem Laboratories Ltd reported a 16.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 22.7%.
- Its expenses for the quarter were up by 10.7% QoQ and 12.8% YoY.
- The net profit increased 89.7% QoQ and decreased 31.1% YoY.
- The earnings per share (EPS) of Unichem Laboratories Ltd stood at 8.2 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 546.71 | 470.95 | 445.66 | 16.1% | 22.7% |
Total Expenses | 484.86 | 437.96 | 429.70 | 10.7% | 12.8% |
Profit Before Tax | 61.85 | 32.99 | 83.97 | 87.5% | -26.3% |
Tax | 4.00 | 2.50 | -0.02 | 60.0% | -20100.0% |
Profit After Tax | 57.85 | 30.49 | 83.99 | 89.7% | -31.1% |
Earnings Per Share | 8.20 | 4.30 | 11.90 | 90.7% | -31.1% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Unichem Laboratories Ltd is a pharmaceutical company primarily engaged in the manufacturing and marketing of pharmaceutical products. The company operates in the pharmaceutical industry, which is characterized by the development, production, and marketing of medications. As of the latest available data, there are no specific recent major developments publicly associated with Unichem Laboratories Ltd. The company continues to focus on its core business of providing high-quality pharmaceutical products to its customers.
Revenue
In the third quarter of fiscal year 2025 (Q3FY25), Unichem Laboratories Ltd reported a total income of ₹546.71 crores. This represents a quarter-over-quarter (QoQ) increase of 16.1% from ₹470.95 crores in Q2FY25. Year-over-year (YoY), the total income increased by 22.7% from ₹445.66 crores in Q3FY24. These figures indicate significant growth in the company's revenue over both the previous quarter and the same quarter in the previous year.
Profitability
The profitability of Unichem Laboratories Ltd during Q3FY25 showed considerable variance when compared to both the previous quarter and the previous year. The profit before tax was reported at ₹61.85 crores, reflecting an 87.5% increase QoQ from ₹32.99 crores in Q2FY25. However, this was a decrease of 26.3% YoY from ₹83.97 crores in Q3FY24. The profit after tax for Q3FY25 was ₹57.85 crores, which marked an 89.7% increase QoQ from ₹30.49 crores but a 31.1% decrease YoY from ₹83.99 crores in Q3FY24. The tax expense stood at ₹4.00 crores, compared to ₹2.50 crores in the previous quarter and a nominal credit in the same quarter of the previous year.
Operating Metrics
The earnings per share (EPS) for Unichem Laboratories Ltd in Q3FY25 was ₹8.20, showing a QoQ increase of 90.7% from ₹4.30 in Q2FY25. However, the EPS decreased by 31.1% YoY from ₹11.90 in Q3FY24. Total expenses for the third quarter of fiscal year 2025 were ₹484.86 crores, which was a 10.7% increase from ₹437.96 crores in Q2FY25 and a 12.8% increase from ₹429.70 crores in Q3FY24. These operating metrics highlight the company's financial performance in terms of profitability and operational efficiency.
